EDUARDO GRUNVALD: Open Payments
NPI 1497791339 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,948 in 7 payments from 3 companies in 2025. Trend: 2023 $6,543 · 2024 $21,407 · 2025 $13,948
Consulting: $13,718Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $13,883 |
| Intra-Sana Laboratories | 1 | $50 |
| Davol Inc. | 1 | $15 |
Products named: Wegovy, RELTONE 200 MG, Phasix Mesh.
Industry payments across CA — which companies pay providers there.
